USPTO 2015–2025 USPTO PatentsView US Corporation

Chainalysis, Inc.

USPTO PatentsView assignee record - 11 granted patents across 1 technology areas, recorded in grant years 2024–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION).

The verdict

According to USPTO PatentsView, Chainalysis ranks #24,083 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 1 technology areas.

#24,083
of 50,000 US assignees by volume
Top 55%
by Innovation Score (33.6/100)
2.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24083 · US Corporation #24,083 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 11 grants
  • MID-PACK #24,083/50,000
  • PHOTO-FINISH Cellview Imaging
  • CPC-NARROW H04L · 1 areas
  • INNOV-THIN 33.6/100
  • CLAIMS-SPARSE 2.5 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2024–2024 · 1y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Cellview Imaging Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Chainalysis

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Chainalysis's Innovation Score is 33.6/100 (top 55% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Chainalysis's grants concentrate

Chainalysis, Inc. is a focused PatentsView assignee: 1 CPC subclasses with 9.1% of grants classified under H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION). By volume, Chainalysis sits between Cellview Imaging Inc. and Chenguang Biotech Group Co., Ltd..

Chainalysis's three-year grant acceleration

Chainalysis, Inc. shows 11 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Chainalysis's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Chainalysis holds 11 patents at rank #24,127, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Chainalysis

By rank, the assignees closest to #24,127 in granted patent volume.

Leaders in H04L (Transmission OF Digital Information)

Other assignees with the most granted patents in Chainalysis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Chainalysis, neither rank-band nor same-CPC leaders (those blocks stay above).

Chainalysis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 Top 55% higher than 45% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table
Chainalysis, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2024 11 100.0%

Which technologies does Chainalysis, Inc. patent most?

Top 1 of 1 technology areas

Where it ranks

Overall rank by patents

#24,083

of 50,000 tracked assignees

Innovation Score

33.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.